- Home
- ICCM vs ORIS Comparison
ICCM vs ORIS Comparison
Compare ICCM & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ICCM | ORIS |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | | Farming/Seeds/Milling |
| Sector | | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.4M | 49.0M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | ICCM | ORIS |
|---|---|---|
| Price | $0.58 | $1.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 175.1K | 100.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $19.87 | N/A |
| Revenue Next Year | $31.38 | N/A |
| P/E Ratio | ★ N/A | $152.96 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.54 | $0.06 |
| 52 Week High | $1.53 | $1.87 |
Technical Indicators
Market Signals| Indicator | ICCM | ORIS |
|---|---|---|
| Relative Strength Index (RSI) | 42.42 | 42.16 |
| Support Level | $0.54 | $0.11 |
| Resistance Level | $0.74 | $1.48 |
| Average True Range (ATR) | 0.03 | 0.12 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 26.94 | 35.36 |
Price Performance
Historical ComparisonAbout ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).